Sign up for our daily briefing
Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.
Catch up on the day's biggest business stories
Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter
Stay on top of the latest market trends
Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.
Sports news worthy of your time
Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.
Tech news worthy of your time
Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.
Get the inside stories
Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Want a daily digest of the top Denver news?
Get a daily digest of the most important stories affecting your hometown with Axios Denver
Want a daily digest of the top Des Moines news?
Get a daily digest of the most important stories affecting your hometown with Axios Des Moines
Want a daily digest of the top Twin Cities news?
Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities
Want a daily digest of the top Tampa Bay news?
Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay
Want a daily digest of the top Charlotte news?
Get a daily digest of the most important stories affecting your hometown with Axios Charlotte
Sign up for Axios NW Arkansas
Stay up-to-date on the most important and interesting stories affecting NW Arkansas, authored by local reporters
MERs is in the same family as the novel coronavirus which began to infect patients in Wuhan, China. Photo: Smith Collection/Gado/Getty Images
Scientists and doctors are exploring whether existing treatments for HIV, Ebola and malaria could combat the coronavirus, the Los Angeles Times reports.
Driving the news: The antiviral remdesivir protected monkeys from MERS, another coronavirus, both before and after exposure, the National Institute of Health announced Thursday.
The medication, made by Gilead, has been used in experiments to fight Ebola, and has also been used to keep SARS from replicating in animals.
- Two other drugs for Ebola and malaria are being used on Chinese patients — one to disrupt covis-19's genetic material and the other to keep the coronavirus from penetrating cells, respectively.
- Doctors are also looking at HIV medication that could block an enzyme the virus needs to mature, per LAT.
Why it matters: An anti-viral or immunotherapy that's already been proven safe could be a faster solution to slowing down infections. But their effectiveness against the coronavirus still has to be tested.
Go deeper: Vaccine candidate for coronavirus on track for human trials